About PSM
Partnership for Safe Medicines Statement on 60 Minutes Segment
Partnership for Safe Medicines Board of Directors’ member Thomas Kubic, President and CEO, Pharmaceutical Security Institute, today issued the following statement regarding last night’s 60 Minutes segment on counterfeit drug sellers. “The global epidemic of fake medicines is a serious public health threat, and consumers’ lack of awareness of it only adds to the danger.…
[...]Partnership for Safe Medicines Commends Introduction of Bill to Crack Down on Prescription Drug Theft
The Partnership for Safe Medicines today commended Senators Chuck Schumer (D-NY), Jay Rockefeller (D-WV), Amy Klobuchar (D-MN) and Sherrod Brown (D-OH) for introducing legislation to curb prescription drug theft
[...]PSM’s Liang in JAMA: Online Direct to Consumer Advertising’s Impact on Illegal Online Pharmacies
Washington, D.C. (February 25, 2011) – Partnership for Safe Medicines Board of Directors’ member Bryan A. Liang, MD, PhD, JD, with colleague Tim Mackey, MAS, published an article in this week’s issue of the Journal of the American Medical Association (JAMA) addressing the online direct to consumer (DTC) advertising market, and specifically how rogue online…
[...]Partnership for Safe Medicines Launches You Tube Channel
The Partnership for Safe Medicines has launched a Safe Medicines YouTube Channel. The Safe Medicines Channel, 23 videos encompassing the entire Safe Medicines Interchange conference on October 8th, 2010, are available for those that missed the conference speakers.
[...]Partnership for Safe Medicines Commends White House Forum on Fake Drugs
Partnership for Safe Medicines Board of Directors’ member Bryan A. Liang, MD, PhD, JD, released the following statement regarding today’s White House forum on the risks of counterfeit medicines.
“I am pleased that the White House continues to address the issue of counterfeit drugs and the serious health risk they pose to Americans – sick or well.
[...]Partnership For Safe Medicines (PSM) India Launches 24-Hour Helpline
The Partnership for Safe Medicines (PSM) India, a group of nonprofit organizations and individuals dedicated to protecting consumers from spurious drugs, today announced the availability of a 24-hour helpline (1800-11-4424) to assist, educate and empower consumers across India.
[...]Partnership For Safe Medicines (PSM) Announces Major International Expansion with Launch of India Initiative
The Partnership for SafeMedicines (PSM), a group of nonprofit organizations and individuals dedicated to protecting consumers from counterfeit drugs, today announced a major expansion of its international coalition with the launch of its partner PSM India.
[...]Partnership for Safe Medicines Commends Successful Global Operation Targeting Online Fake Drug Sellers
The Partnership for Safe Medicines (PSM) today applauded a multi-national effort that resulted in 76 people being arrested or placed under investigation for selling counterfeit drugs online. Operation Pangea III was coordinated by INTERPOL.
[...]PSM Interchange Conference 2010
PSM’s Inaugural 2010 Interchange On Oct. 8th in Washington DC, global experts discussed key issues around the problem of counterfeit drugs and the ways to promote access to safe medicines. The event was covered by C-SPAN. Visit our archives to view the event
[...]FDA Commissioner Margaret Hamburg Joins with Public and Private Sector Leaders in Call to Address Global Counterfeit Drug Crisis
Washington, D.C. (October 8, 2010) – The U.S. Food and Drug Administration (FDA) is committed to keeping American drugs safe and needs new regulatory authority to do so, said Dr. Margaret Hamburg, Commissioner of the FDA, in prepared remarks at today’s inaugural Counterfeit Drug Interchange Conference hosted by the Partnership for Safe Medicines (PSM). The conference brought together more than a hundred cross-industry stakeholders to discuss ways to stem the rising tide of counterfeit and unsafe medicines.
“The FDA is firmly committed to doing all that we can to further strengthen our nation’s drug supply and ensure the quality and safety of all drugs and medical products on the U.S. market,” said Hamburg. “It is clear that FDA needs new regulatory tools that provide the authority we need to meet the challenges we face in today’s increasing globalized marketplace. And we look forward to working with Congress on legislation that will give FDA the ability to protect Americans from harmful drugs and medical products—and fulfill our fundamental public health mission.”
[...]